• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 2
  • 2
  • 1
  • 1
  • Tagged with
  • 9
  • 9
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Autoimmune encephalitis and its implications for the neuroscience of remote memory

Miller, Thomas D. January 2017 (has links)
Since the field-defining patient HM, consistent links have been made between a region of the brain called the hippocampus and memories that can be consciously declared - so called declarative memories. Declarative memories fall into two categories (1) episodic memories, memories that are highly detailed and re-experiential, and (2) semantic memories, fact-based memories for personal and public information but that have no sense of re-experiencing. It is believed that the intrinsic anatomy of the hippocampus supports episodic memory but not semantic memory. The hippocampus consists of five regions (cornu Ammonis, CA, 1-3, dentate gyrus, subiculum) with each purported to have a specific role in episodic memory acquisition and retrieval. However, controversy surrounds the temporal extent to which episodic memories rely on the hippocampus for retrieval: current consensus suggests the hippocampus supports these memories for five-10 years post-acquisition, but some suggest that it is required for retrieval across the lifetime. Voltage-gated potassium channel-complex antibody-mediated limbic encephalitis (VGKC-complex LE) is a recently described autoimmune disease that causes chronic hippocampal atrophy and mild amnesia on standardized neuropsychological assessment. Two subfields of the hippocampus - CA1 and CA3 - contain the antigenic targets of the disease but it is unknown if specific atrophy of these subfields underlies the hippocampal damage in humans. Here, the human hippocampal subfield volumes of VGKC-complex LE patients (n = 19, mean age: 64.0±2.55; range: 24-71) were investigated using ultra-high spatial resolution MRI at 7.0-Tesla. Assessment also included standardized neuropsychology to examine the impact of the pathology on hippocampal-dependent and -independent memory performance, as well as attention, language, executive function, and perception Declarative memory assessment measured semantic and episodic memory performance across the lifespan. Manual segmentation detected lesions to just CA3, with no volume loss noted elsewhere in the hippocampus or brain. Patients were impaired on hippocampal-dependent memory domains but not the hippocampal-independent and non-memory domains. Notably, episodic memory assessment revealed episodic amnesia across the lifetime except for their earliest memories. This counters the received convention that the hippocampus has a temporally limited role in episodic retrieval. Conversely, the performance of the VGKC-complex LE patients for semantic memory, including a new test developed herein, was comparable to controls across the lifespan. It was then shown that CA3 volume predicted episodic memory performance across the lifetime. Together, the results suggest that VGKC-complex LE provides a novel model of human hippocampal subfield pathology, with which to explore the roles of hippocampal subfields in episodic memory acquisition and retrieval.
2

Autoantibodies to N-methyl D-aspartate receptors in autoimmune encephalitis

Bera, Katarzyna D. January 2011 (has links)
N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is a recently described autoimmune encephalopathy defined by the presence of serum antibodies that bind NMDARs (NMDAR-Abs). NMDAR-Ab encephalitis is a severe, but treatmentresponsive encephalitis with subacute onset. It can be associated with tumours and affects mainly young adults. Patients present with cognitive dysfunction, seizures, psychiatric and sleep disorders and most develop dyskinesias, autonomic instability and reduced consciousness. To explore further the NMDAR-Abs and their potential pathogenicity, a series of in vitro investigations were performed and preliminary attempts at passive transfer of disease. Human embryonic kidney (HEK) cells transfected with the NR1 and NR2B subunits, and live cultured neurons, were used first to detect NMDAR-Ab binding. Immunocytochemistry and ow cytometry demonstrated that binding to transfected HEK cells could be improved when NMDAR were presented in clusters by cotransfection with the postsynaptic density protein PSD-95. The NR1 subunit was identified as the target of NMDAR-Abs, and a novel quantitative assay based on immunoprecipitation of NR1 tagged by fusion with green uorescent protein was developed. Measurement of NMDAR-Ab levels showed that antibody levels corresponded to the clinical disease score within individual patients. Although the purification of full length NR1 was not successful, a secreted N-terminal construct was created and expressed in HEK cells. The binding of NMDAR-Abs was confirmed and this construct will be used for active immunisation in future. To explore pathogenic mechanisms in vitro, the main antibody subclasses were shown to be IgG1 and IgG3. Moreover the patients' autoantibodies, but not healthy control antibodies, were able to activate the complement cascade in vitro in cell lines and primary cultures. Finally, the NMDAR-Abs were shown to bind to primary microglial cultures and to cause morphological changes corresponding to early activation processes after prolonged exposure. The research has developed new assays that could be used for diagnosis and serial studies and revealed new potential mechanisms in NMDAR-Ab encephalitis.
3

Autoimmunity in idiopathic epilepsies and encephalopathies of childhood

Wright, Sukhvir January 2014 (has links)
Immune mechanisms are thought to be involved in the pathological disease process in a number of childhood epileptic syndromes and encephalitis. Of particular interest is the occurrence of autoantibodies to essential neuronal proteins, for example the N-methyl-D-aspartate receptor (NMDAR), in the blood and spinal fluid in some of these patients. The aims of this study were: to examine the sera of newly diagnosed paediatric epilepsy patients for specific neuronal autoantibodies, correlate to epilepsy phenotype and disease outcomes; to investigate the pathogenicity and epileptogenicity of central nervous system autoantibodies (CNS) in vivo; and to test new therapies in vitro and in vivo based on the potential pathogenic mechanisms. In 290 paediatric patients with new-onset epilepsy and seizures tested for CNS autoantibodies, 11.4% were positive (33/290 versus 8/112 in controls; p=0.01, Fisher's exact test). Previously unreported contactin-2 antibody positive and contactin-associated-protein 2 (CASPR2) antibody positive epilepsy patients were described. Patients with 'focal epilepsy of unknown cause' were more likely to be antibody positive. To test the pathogenicity and epileptogenicity of these antibodies, a novel in vivo telemetry system was used to continuously record electroencephalogram (EEG) in mice injected into the cerebral lateral ventricle with NMDAR antibody (NMDAR-Ab) positive immunoglobulin (IgG). Although no spontaneous seizures were seen, mice challenged with the pro-convulsant pentylenetetrazole (PTZ) had increased seizure susceptibility, and more epileptiform "spikes" in the EEG after PTZ compared to healthy control (HC) IgG injected mice. Seizure susceptibility strongly correlated with binding intensity of NMDAR-Ab IgG analysed in post-mortem tissue. Given the hypothesis this epileptogenic effect was mediated by NMDAR-Abs internalising cell surface NMDARs, and to try and rescue this deficit, a neurosteroid, pregnenolone sulphate (PregS) known to increase NMDAR cell surface expression, was therapeutically used. This approach worked in vitro, and although in vivo effects were not yet established, treatment with neurosteroids may be beneficial for autoantibody mediated neurological disease.
4

Encéphalites à anticorps anti-NMDAR : étude clinique et mécanistique / Anti-NMDAR autoimmune encephalitis : clinical and mechanistic study

Bost, Chloé 20 October 2017 (has links)
Les encéphalites à anticorps (Ac) anti-récepteur NMDA (NMDAR) sont des pathologies auto-immunes nouvellement décrites ciblant un récepteur majeur du système nerveux central, le NMDAR. Les synapses glutamatergiques assurent la majeure partie de la transmission excitatrice du cerveau et les récepteurs ionotropiques au glutamate de type NMDA ont un rôle clé dans la plasticité synaptique, c'est-à-dire les modifications de la force de transmission synaptique constituant le corrélat cellulaire des processus d'apprentissage et de mémoire. Les études in vitro et in vivo de l'effet des Ac anti-NMDAR tendent à montrer une altération de la dynamique des NDMAR et une internalisation. Les Ac auraient un effet pathogénique pouvant expliquer des symptômes. Au cours de ma thèse, j'ai souhaité approfondir la compréhension de cette pathologie sur le plan clinique et mécanistique. Pour cela j'ai étudié les caractéristiques cliniques et histologiques des patients présentant une tumeur maligne associée, me permettant d'établir des recommandations de prise en charge au vu du taux de mortalité plus élevé chez ces patients et d'une fréquence plus importante de tératomes ovariens immatures que dans la population générale. En parallèle j'ai étudié l'effet des Ac anti-NMDAR sur la transmission et la plasticité synaptique dans un modèle murin d'administration chronique des anticorps. Ces études menées en électrophysiologie sur tranches aigües m'ont permis de mettre en évidence un effet des anticorps du LCR sur la plasticité synaptique significatif mais d'amplitude moindre que les études in vitro l'avaient suggéré. Nous avons également montré l'importance de la durée d'exposition aux anticorps / Anti-NMDAR autoimmune encephalitis is a newly described pathology, characterized by the presence of IgG antibodies (Abs) directed against NMDA receptor (NMDAR). Glutamatergic synapses are the main component of excitatory transmission in the adult brain and the ionotropic glutamate receptor NMDAR has a key role in synaptic plasticity. Synaptic plasticity is defined by the synapses property to modify their transmission strength and seems to be the cellular correlate of learning and memory. In vitro and in vivo studies on anti-NMDAR Abs effects showed an altered dynamic at the membrane followed by an internalization of NMDAR. Thus, Abs seem to have a pathogenic effect, able to explain clinical symptoms. During my thesis, I wanted to deepen the understanding of this pathology on the clinical and mechanistic level. To this end, I studied the clinical and histological features of patients with an associated tumor. Results obtained allow me to establish management recommendations considering the high mortality rate in these patients and a higher frequency of immature ovarian teratomas than in the general population. Simultaneously, I studied the effect of anti-NMDAR Abs on synaptic transmission and plasticity in a murine model allowing chronic Abs infusion. These results obtained by electrophysiology on acute slices allowed me to demonstrate an effect of CSF Abs on synaptic plasticity but of less amplitude that the in vitro studies had suggested. Results also highlighted the importance of the duration to antibodies exposure
5

Imunomodulação da encefalomielite autoimune experimental pelo extrato da glândula salivar de Aedes aegypti. / Immunomodulation of experimental autoimmune encephalomyelitis by salivary gland extract of Aedes aegypti.

Ramos, Anderson Daniel 19 September 2014 (has links)
A saliva de insetos hematófagos possui moléculas capazes de modular o sistema imune do hospedeiro. Com base na literatura a respeito das atividades presentes na saliva de Aedes aegypti, investigamos se o EGS dessa espécie era capaz de modular a EAE. Imunizamos animais C57BL/6 com MOG35-55, e realizamos um tratamento com EGS. O tratamento com EGS diminuiu a incidência da doença e provocou um atraso no aparecimento dos sinais clínicos, além de estes serem mais brandos. Observamos que a modulação se deu na fase de indução da resposta imune, não na efetora. De fato, o EGS consegue suprimir a doença por 4 vias: 1) diminuindo a expressão de MHCII, CD80 e CD86 em células dendríticas, e diminuindo a produção de citocinas responsáveis pela indução das respostas Th1/Th17; 2) induzindo células produtoras de IL-10 in vivo; 3) induzindo apoptose em linfócitos T naive; 4) induzindo células com perfil Th2 produtoras de IL-4 e IL-5. Concluímos que o EGS é capaz de atuar na supressão dos sintomas durante o curso da EAE e na inibição do início da resposta imune. / The saliva of hematophagous insects has molecules that can modulate the host immune system. Based on the literature about activities found in Aedes aegypti saliva, we investigate if SGE of this species could modulate EAE. We have immunized C57BL/6 mice with MOG35-55, and carried out a treatment with SGE. The treatment with SGE reduced the incidence of disease and caused a delay onset of clinical signs making them softer. We have observed that modulation occured in the induction phase of immune response, not in effector phase. In fact, SGE can suppress the disease by four ways: 1) decreasing the expression of MHCII, CD80 and CD86 in dendritic cells and decreasing the production of cytokines responsible for Th1/Th17 response induction; 2) inducing cells producing IL-10 in vivo; 3) inducing apopotosis in naive T lymphocytes; 4) inducing cells Th2 producing IL-4 e IL-5. We came to the conclusion that SGE can act in supressing symptoms during the course of EAE and inhibiting the beggining of autoimmune response.
6

Imunomodulação da encefalomielite autoimune experimental pelo extrato da glândula salivar de Aedes aegypti. / Immunomodulation of experimental autoimmune encephalomyelitis by salivary gland extract of Aedes aegypti.

Anderson Daniel Ramos 19 September 2014 (has links)
A saliva de insetos hematófagos possui moléculas capazes de modular o sistema imune do hospedeiro. Com base na literatura a respeito das atividades presentes na saliva de Aedes aegypti, investigamos se o EGS dessa espécie era capaz de modular a EAE. Imunizamos animais C57BL/6 com MOG35-55, e realizamos um tratamento com EGS. O tratamento com EGS diminuiu a incidência da doença e provocou um atraso no aparecimento dos sinais clínicos, além de estes serem mais brandos. Observamos que a modulação se deu na fase de indução da resposta imune, não na efetora. De fato, o EGS consegue suprimir a doença por 4 vias: 1) diminuindo a expressão de MHCII, CD80 e CD86 em células dendríticas, e diminuindo a produção de citocinas responsáveis pela indução das respostas Th1/Th17; 2) induzindo células produtoras de IL-10 in vivo; 3) induzindo apoptose em linfócitos T naive; 4) induzindo células com perfil Th2 produtoras de IL-4 e IL-5. Concluímos que o EGS é capaz de atuar na supressão dos sintomas durante o curso da EAE e na inibição do início da resposta imune. / The saliva of hematophagous insects has molecules that can modulate the host immune system. Based on the literature about activities found in Aedes aegypti saliva, we investigate if SGE of this species could modulate EAE. We have immunized C57BL/6 mice with MOG35-55, and carried out a treatment with SGE. The treatment with SGE reduced the incidence of disease and caused a delay onset of clinical signs making them softer. We have observed that modulation occured in the induction phase of immune response, not in effector phase. In fact, SGE can suppress the disease by four ways: 1) decreasing the expression of MHCII, CD80 and CD86 in dendritic cells and decreasing the production of cytokines responsible for Th1/Th17 response induction; 2) inducing cells producing IL-10 in vivo; 3) inducing apopotosis in naive T lymphocytes; 4) inducing cells Th2 producing IL-4 e IL-5. We came to the conclusion that SGE can act in supressing symptoms during the course of EAE and inhibiting the beggining of autoimmune response.
7

Aktivierung und Differenzierung von T-Lymphozyten durch Infektion und Autoimmunität

Kamradt, Thomas 29 May 2001 (has links)
Klinische, epidemiologische und experimentelle Daten deuten darauf hin, dass Autoimmunkrankheiten wie z.B. rheumatoide Arthritis, multiple Sklerose oder Typ I Diabetes durch Infektionen ausgelöst oder verschlimmert werden können. Bis heute ist jedoch nicht bekannt, welche molekularen und zellulären Mechanismen den Zusammenhang zwischen Infektion und Autoimmunität vermitteln. Eine Hypothese, die diesen Zusammenhang zu erklären versucht, ist die Hypothese der molekularen Mimikry. Dieser Hypothese zufolge sind kreuzreaktive Lymphozyten, die sowohl Selbst- als auch Fremdantigene erkennen, für die Induktion von Autoimmunität verantwortlich. Die Hypothese der molekularen Mimikry erklärt die Kreuzreaktivität von Lymphozyten durch Sequenzhomologie oder Identität von Selbst- und Fremdantigenen. Wir haben diese Hypothese an zwei Modellen, der chronischen Lyme Arthritis und einem Maus Modell der multiplen Sklerose, getestet und dabei festgestellt, dass Kreuzreaktivität von Lymphozyten weitaus häufiger ist als bis vor kurzem noch vermutet wurde. Wir konnten weiterhin zeigen, dass nicht die Primärstruktur sondern definierbare strukturelle Motive die Ursache für die Kreuzerkennung von Selbst- und Fremdpeptiden sind, und das Kreuzreaktivität in den seltensten Fällen von pathogenetischer Relevanz ist. Die Vorstellung, immunologische Kreuzreaktivität zwischen einem definierten mikrobiellen Antigen und einem definierten Selbstantigen sei für die Pathogenese von Autoimmunkrankheiten verantwortlich, ist also zu einfach. Der zweite Schwerpunkt dieser Arbeit ist die immunologische Analyse eines von uns charakterisierten Th2-spezifisch exprimierten Moleküls, T1/ST2. Wir konnten zeigen, dass T1/ST2 auf Th2, nicht jedoch Th1-Zellen exprimiert wird; dass die Expression von T1/ST2 ex vivo die Lokalisation aktueller Th2-Antworten widerspiegelt; und dass T1/ST2 von funktioneller Bedeutung für die Th2 Zellen ist: Kreuzvernetzung des T1/ST2 Moleküls durch einen T1/ST2-spezifischen monoklonalen Antikörper induziert Proliferation und die Produktion von Typ 2 Zytokinen. In vivo läßt sich durch Applikation des löslichen Antikörpers gegen T1/ST2 die pathogene Th2-Immunantwort im Mausmodell von Asthma modulieren. T1/ST2 ist also ein Kandidat für die gezielte immunmodulatorische Therapie Th2-dominierter Erkrankungen wie Asthma und Allergie. / Clinical, epidemiological, and experimental data suggest that infections can sometimes trigger or exacerbate autoimmune diseases such as multiple sclerosis, type I diabetes, or rheumatoid arthritis. To date, the molecular and cellular mechanisms leading from infection to autoimmunity have not been defined. The molecular mimicry hypothesis proposes that crossreactive lymphocytes that recognize both self- and microbial antigens are key factors in the pathogenesis of autoimmunity. According to the molecular mimicry hypothesis, sequence identity or marked sequence similarity between self- and microbial antigens is the cause of such crossreactivity. We have examined the molecular mimicry hypothesis systematically in two different models: treatment-resistant Lyme arthritis and experimental autoimmune encephalitis (EAE). The major findings were: i) crossreactivity at the level of peptide recognition by T cells is far more frequent than previously expected; ii) structural criteria rather than sequence similarity determine cross-recognition; iii) immunoregulatory mechanisms normally prevent pathogenic effects mediated by crossreactive lymphocytes. Thus, the idea that crossrecognition of a defined microbial peptide and a particular self-peptide would explain autoimmunity is most likely too simple. The other major topic of this work was the immunological analysis of T1/ST2, a Th2-specific molecule that we characterized. Here, we could show that T1/ST2 is expressed on Th2 but not Th1 cells. Furthermore, T1/ST2 expression can be used to identify sites of ongoing Th2 reactions directly ex vivo. Most importantly, T1/ST2 is important for Th2 effector functions: crosslinking of T1/ST2 via a T1/ST2-specific monoclonal antibody induces proliferation and type 2-cytokine production. In vivo, administration of the soluble antibody against T1/ST2 ameliorates the immunological parameters of bronchial hyperreactivity in a murine model of asthma. Thus, T1/ST2 is a candidate target for therapeutic immunomodulation of diseases such as allergy and asthma.
8

Th17 cells – oligodendrocytes interactions in multiple sclerosis : damage, death and adhesion mechanisms

Jamann, Hélène 08 1900 (has links)
La sclérose en plaques (SP) est une maladie neuro-inflammatoire caractérisée par l’invasion de cellules immunitaires périphériques dans le système nerveux central (SNC), entraînant une perte de myéline à des endroits bien délimités appelés « plaques » ou lésions. Les processus neuroinflammatoires sont associés au dommage des neurones et oligodendrocytes (OLs) en SP. Les mécanismes sous-tendant cette dégradation des OLs par les cellules immunitaires en SP sont toutefois encore mal compris. Les lymphocytes T CD4 activés, notamment les sous-types proinflammatoires Th1 et Th17, jouent un rôle clé dans la pathobiologie de la SP et de son modèle murin l’encéphalite auto-immune expérimentale (EAE). Nous avons donc choisi d’investiguer leur contribution à l’endommagement des OLs en neuroinflammation. Pour ce faire, nous avons premièrement caractérisé les interactions entre les lymphocytes Th17 et les OLs matures in vivo à l’aide de l’imagerie intravitale chez la souris EAE (microscopie deux photons) et in vitro en utilisant des cultures primaires humaines. Ceci nous a permis de mettre en évidence que les lymphocytes pro-inflammatoires Th17 adhèrent de façon prolongée aux OLs et leur causent plus de dommage que les lymphocytes anti-inflammatoires Th2. Après avoir établi que le contact avec les lymphocytes Th17 entraîne tout d’abord la perte des prolongements cellulaires puis la mort des OLs, nous avons identifié deux mécanismes à l’origine de ces dommages. En effet, tandis que la sécrétion de glutamate par les lymphocytes Th17 à proximité des OLs entraîne une perte des prolongements cellulaires de ces derniers et une diminution de leur capacité à myéliniser, la sécrétion de granzyme B mène à la mort des OLs. Dans le but de comprendre comment prévenir les dommages causés par les lymphocytes Th17 aux OLs en SP, nous avons par la suite étudié les mécanismes sous-tendant le contact entre les deux types cellulaires. Comme nous avons confirmé que les OLs matures n’expriment pas le MHC II au niveau protéique, nous avons caractérisé l’expression par les OLs de molécules d’adhérence cellulaire (CAMs) qui seraient susceptibles de sous-tendre l’adhérence des lymphocytes Th17. Nous avons découvert que cette interaction est notamment médiée par ALCAM, et que bloquer cette molécule permet de diminuer le dommage aux OLs médié par les Th17 in vitro. A l’inverse, l’expression et/ou la sécrétion d’ICAM-1 par les OLs semble avoir un effet protecteur face aux lymphocytes Th17. En résumé, nous avons distingué de nouveaux mécanismes impliqués dans le dommage aux OLs en neuroinflammation et identifié de nouvelles cibles thérapeutiques prometteuses pour la protection des OLs en SP. / Multiple Sclerosis (MS) is a neuroinflammatory disease characterized by infiltration of immune cells into the central nervous system (CNS), demyelination in multifocal areas called “plaques” or lesions, and damage to neurons and oligodendrocytes (OLs). The mechanisms underlying immune-mediated injury to OLs in MS remains only partially understood. Activated CD4 T cells, in particular pro-inflammatory subsets Th1 and Th17, play an important role in the pathobiology of MS and its animal model experimental autoimmune encephalitis (EAE). We set out to investigate their contribution to immune-mediated oligodendrocytic damage in neuroinflammation. We first characterized the interactions between Th17 cells and mature OLs in vivo using live imaging of EAE mice (two photon microscopy) and in vitro using human primary cell cultures. We found that pro-inflammatory Th17 cells form prolonged contacts with OLs and cause greater harm compared to anti-inflammatory Th2 cells. After demonstrating that contact with Th17 cells leads first to destruction of cell processes and then death of OLs, we identified two mechanisms underlying these deleterious impacts. Indeed, while secretion of glutamate by Th17 cells in contact with OLs is associated with damage to OLs cell processes and impairment of their myelinating capacity, secretion of granzyme B leads to OLs death. To better understand how to prevent Th17-mediated OLs injury in MS, we next studied mechanisms involved in the interaction between these two cell types. As we confirmed that mature OLs do not express MHC II at the protein level, we characterized expression of cell adhesion molecules (CAMs) by OLs that could mediate Th17 cell adhesion. We discovered that ALCAM contributes to OLs and Th17 cells interactions, and that blocking this olecule reduces Th17-mediated OL damage in vitro. Inversely, ICAM-1 expression and/or secretion by OLs seems to have a protective effect in neuroinflammatory conditions. In summary, we have uncovered new mechanisms implicated in OLs njury in neuroinflammation and have identified potential novel therapeutic targets for neuroprotection in MS.
9

Imaging of cognitive outcomes in patients with autoimmune encephalitis / Insights from neuropsychological assessments to functional brain networks

Heine, Josephine 13 July 2022 (has links)
Die Autoimmunenzephalitis ist eine kürzlich beschriebene entzündliche Erkrankung des zentralen Nervensystems, die Gedächtnisdefizite, Psychosen, oder epileptische Anfälle hervorrufen kann. Derzeit ist hingegen noch nicht ausreichend verstanden, welche pathologischen Veränderungen zu den kognitiven Defiziten führen und welche neuropsychologischen und bildgebenden Langzeitoutcomes zu erwarten sind. Anhand von strukturellen und funktionellen Bildgebungsanalysen zeigt diese Dissertation, dass kognitive Defizite auch nach der akuten Phase der Autoimmunenzephalitis fortbestehen können. Bei der LGI1-Enzephalitis gehen Gedächtnisdefizite mit fokalen strukturellen Läsionen im Hippocampus einher. Durch eine funktionelle Störung der Resting-State-Konnektivität des Default-Mode- und Salienznetzwerkes beeinträchtigen diese Hippocampusläsionen auch Hirnregionen außerhalb des limbischen Systems. Bei Patient:innen mit NMDA-Rezeptor-Enzephalitis finden sich in der longitudinalen neuropsychologischen Untersuchung trotz guter allgemeiner Genesung auch noch mehrere Jahre nach der Akutphase persistierende Defizite des Gedächtnisses und exekutiver Funktionen. Zuletzt zeigt eine transdiagnostische Analyse, dass der anteriore Hippocampus eine erhöhte Vulnerabilität gegenüber immunvermittelten pathologischen Prozessen aufweist. Diese Ergebnisse legen nahe, dass kognitive Symptome auch noch nach der Entlassung aus der stationären Behandlung fortbestehen können. Sowohl umschriebene strukturelle Hippocampusläsionen als auch Veränderungen in makroskopischen funktionellen Hirnnetzwerken tragen zur pathophysiologischen Erklärung dieser Symptome bei. Zudem erlauben diese Ergebnisse einen Einblick in neuroplastische Veränderungen des Gehirns und haben weitreichende Implikationen für die Langzeitversorgung und das Design zukünftiger klinischer Studien. / Autoimmune encephalitis is a recently described inflammatory disease of the central nervous system that can cause memory deficits, psychosis, or seizures. The trajectory of cognitive dysfunction and the underlying long-term imaging correlates are, however, not yet fully understood. By using advanced structural and functional neuroimaging, this thesis shows that cognitive deficits persist beyond the acute phase. In LGI1 encephalitis, MRI postprocessing revealed that memory deficits are related to focal structural hippocampal lesions. These hippocampal lesions propagate to brain areas outside the limbic system through aberrant resting-state connectivity of the default mode network (DMN) and the salience network. In NMDA receptor encephalitis, a longitudinal analysis of neuropsychological data describes persistent cognitive deficits, especially in the memory and executive domains, despite good physical recovery several years after the acute disease. Lastly, a transdiagnostic analysis reveals that the anterior hippocampus is particularly vulnerable to immune-mediated damage. In conclusion, these results demonstrate that cognitive symptoms in autoimmune encephalitis can persist beyond discharge from neurological care. Both discrete structural hippocampal damage and changes in macroscopic functional networks shed light on the pathophysiological basis of these symptoms. These findings help to explain how the brain responds to pathological damage and have substantial implications for long-term patient care and the design of future clinical studies.

Page generated in 0.0734 seconds